Amphastar Pharmaceuticals, Inc. (AMPH) Free cash flow 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$121.2MFY2025 · since FY2016: $17.2M → $121.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $121.2M | -29.7% |
| FY2024 | $172.3M | +18.6% |
| FY2023 | $145.3M | +123.1% |
| FY2022 | $65.1M | -7.6% |
| FY2021 | $70.5M | +201.3% |
| FY2020 | $23.4M | +11209.7% |
| FY2019 | $207,000 | +102.4% |
| FY2018 | -$8.6M | -309.7% |
| FY2017 | $4.1M | -76.1% |
| FY2016 | $17.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice